Skip to main content

Coronavirus: Vaccination

Question for Department of Health and Social Care

UIN 49091, tabled on 14 September 2021

To ask the Secretary of State for Health and Social Care, whether doses of the Astrazeneca Covishield have been rebranded as Vaxzevria upon distribution to UK citizens.

This answer is the replacement for a previous holding answer.

Answered on

22 September 2021

No doses of the AstraZeneca Covishield branded vaccines have been purchased by the Government. All AstraZeneca vaccine doses approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and administered in the United Kingdom were branded as the ’COVID-19 vaccine AstraZeneca’ which is now known commercially as ‘Vaxzeria’. The MHRA has not approved doses branded as ‘Covishield’ and none have been administered or rebranded as Vaxzevria in the UK. All AstraZeneca vaccines are the same product and appear on the NHS COVID Pass as Vaxzevria.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.